Stryker Corporation (SYK) Stock Analysis — Probabli.AI
AI-powered analysis for SYK (Stryker Corporation): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
← Healthcare Stocks
Last price: $321.43 · Market cap: $125.4B · AI outlook: Bullish
Stryker Corporation is well-positioned for future growth driven by its innovative product offerings in the medical devices space, consistent earnings outperformance, and favorable analyst sentiment. While there are risks like supply chain issues and competitive pressures, the company’s focus on advanced technologies and global market presence enhances its growth potential significantly.
Probabilistic 1-Year Outlook
- Bull 40% · Neutral 50% · Bear 10%
- 1-year price estimates — P10: $300 / P50: $375 / P90: $420
- Stryker Corporation has a strong track record of earnings beats and enjoys high analyst targets. Its growth potential is bolstered by strategic investments in cutting-edge medical technologies.
5-Year Outlook
- Bull 50% · Neutral 40% · Bear 10%
- 5-year price estimates — P10: $300 / P50: $500 / P90: $700
SWOT Highlights
- Strength: Strong brand and reputation in medical devices.
- Strength: Consistent earnings beats and analyst support.
- Risk: Exposure to supply chain disruptions.
- Risk: High dependency on regulatory approvals.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
14 Wall Street analysts rate SYK a BUY with a mean price target of $415.57. Stryker Corporation currently pays a dividend with a yield of approximately 1.10%.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
SYK forecast details · SYK sentiment details · SYK insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.